|
Nov 6
|
Aclaris Therapeutics (ACRS) Reports Q3 Loss, Misses Revenue Estimates
|
|
Nov 6
|
Aclaris: Q3 Earnings Snapshot
|
|
Nov 6
|
Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
|
|
Oct 9
|
Millennium Management LLC Reduces Stake in Aclaris Therapeutics Inc
|
|
Oct 8
|
Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year?
|
|
Jun 6
|
Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
|
|
May 10
|
Earnings Update: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Just Reported And Analysts Are Boosting Their Estimates
|
|
May 8
|
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Q1 2024 Aclaris Therapeutics Inc Earnings Call
|
|
May 8
|
Aclaris Therapeutics Inc (ACRS) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
|
|
May 7
|
Aclaris Therapeutics (ACRS) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 7
|
Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
|
|
Apr 30
|
Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to Provide Corporate Update
|
|
Apr 23
|
Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer
|
|
Apr 11
|
Favourable Signals For Aclaris Therapeutics: Numerous Insiders Acquired Stock
|
|
Mar 20
|
Is Aclaris Therapeutics (ACRS) Stock Outpacing Its Medical Peers This Year?
|
|
Mar 4
|
Aclaris (ACRS) Upgraded to Buy: Here's Why
|
|
Mar 4
|
Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year?
|
|
Jan 17
|
Aclaris (ACRS) Stock Rises on Appointment of New Interim CEO
|
|
Jan 16
|
Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review
|